Results

RDF/XMLNTriplesTurtleShow queryShare ▶
SubjectPredicateObject
http://purl.uniprot.org/citations/24103454http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/24103454http://www.w3.org/2000/01/rdf-schema#comment"

Background

microRNAs have been shown to regulate the chemosensitivity of cancer cells. The aim of this study is to investigate the role and mechanism of mir-23a in enhancing the anti-tumor effect of topoisomerase 2A (TOP2A) poison etoposide in human hepatocellular carcinoma (HCC).

Methods

The anti-tumor effect of chemotherapeutic agents in HCC cells were examined in vitro and in vivo xenograft model. Expression of mRNA and miRNAs were determined by quantitative real-time PCR. Protein expression was analyzed by immunoblotting.

Results

Overexpression of mir-23a could significantly potentiate the in vitro and in vivo anti-tumor effect of etoposide; however, ectopic expression of miR-23a fails to sensitize HCC cells to 5-fluorouracil treatment, indicating the miR-23a-induced cancer cell hypersensitivity in chemotherapy is TOP2A-specific though miR-23a overexpression could not directly up-regulate TOP2A expression. Topoisomerase 1(TOP1) is down-regulated in miR-23a-overexpressed HCC cells. MiR-23a could directly bind to 3'untranslated region of TOP1 mRNA, and suppress the corresponding protein expression and inhibition of miR-23a further arguments the expression of TOP1. MiR-23a was up-regulated during DNA damage in cancer cells in line with the p53 expression. Up-regulation of p53 induces mir-23a expression, while suppression of p53 inhibits miR-23a in HCC cells.

Conclusion

Our study sheds light on the role of miR-23a as a potential target in regulating chemosensitivity of HCC cells."xsd:string
http://purl.uniprot.org/citations/24103454http://purl.org/dc/terms/identifier"doi:10.1186/1476-4598-12-119"xsd:string
http://purl.uniprot.org/citations/24103454http://purl.uniprot.org/core/author"Feng Y."xsd:string
http://purl.uniprot.org/citations/24103454http://purl.uniprot.org/core/author"Zhang Z."xsd:string
http://purl.uniprot.org/citations/24103454http://purl.uniprot.org/core/author"Tsao S.W."xsd:string
http://purl.uniprot.org/citations/24103454http://purl.uniprot.org/core/author"Wang N."xsd:string
http://purl.uniprot.org/citations/24103454http://purl.uniprot.org/core/author"Zhu M."xsd:string
http://purl.uniprot.org/citations/24103454http://purl.uniprot.org/core/author"Man K."xsd:string
http://purl.uniprot.org/citations/24103454http://purl.uniprot.org/core/date"2013"xsd:gYear
http://purl.uniprot.org/citations/24103454http://purl.uniprot.org/core/name"Mol Cancer"xsd:string
http://purl.uniprot.org/citations/24103454http://purl.uniprot.org/core/pages"119"xsd:string
http://purl.uniprot.org/citations/24103454http://purl.uniprot.org/core/title"MiR-23a-mediated inhibition of topoisomerase 1 expression potentiates cell response to etoposide in human hepatocellular carcinoma."xsd:string
http://purl.uniprot.org/citations/24103454http://purl.uniprot.org/core/volume"12"xsd:string
http://purl.uniprot.org/citations/24103454http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/24103454
http://purl.uniprot.org/citations/24103454http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/24103454
http://purl.uniprot.org/uniprot/#_B9EG90-mappedCitation-24103454http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/24103454
http://purl.uniprot.org/uniprot/#_Q6PK95-mappedCitation-24103454http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/24103454
http://purl.uniprot.org/uniprot/#_P11387-mappedCitation-24103454http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/24103454
http://purl.uniprot.org/uniprot/#_Q6NWZ5-mappedCitation-24103454http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/24103454
http://purl.uniprot.org/uniprot/#_Q9BVT2-mappedCitation-24103454http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/24103454
http://purl.uniprot.org/uniprot/P11387http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/24103454
http://purl.uniprot.org/uniprot/Q6NWZ5http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/24103454
http://purl.uniprot.org/uniprot/Q9BVT2http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/24103454
http://purl.uniprot.org/uniprot/B9EG90http://purl.uniprot.org/core/mappedCitationhttp://purl.uniprot.org/citations/24103454
▶